Journal of the Iranian Chemical Society
J=6.4 Hz CH2), 6.78 (1H, s, ArH), 7.26–7.34 (2H, m, ArH),
CH3), 1.16 (3H, s, CH3), 2.10 (2H, s, CH2), 2.21 (2H, s,
CH2), 3.52 (2H, q, J = 6.1 Hz, CH2), 6.64 (1H, m, ArH),
6.71–7.04 (3H, m, ArH), 7.80 (2H, s, NH2), 10.25 (1H, s,
NH) ppm.
7.35 (2H, s, NH2), 10.57 (1H, s, NH) ppm.
2‑Amino‑1′,2′,5,6,7,8‑hexahydro‑7,7‑dimethyl‑2′,5‑dio
xo‑1′‑(phenylmethyl)spiro[4H‑1‑benzopyran‑4,3′‑[3H]
indole]‑3‑carbonitrile (5e) M.p.: 268–270 °C; FTIR (KBr):
Vmax =3346, 2962, 2197, 1716, 1661, 1218 cm−1; 1H NMR
(DMSO-d6, 400 MHz): δ = 1.01 (6H, s, 2CH3), 2.10 (2H,
s, CH2), 2.42 (2H, s, CH2), 4.91 (2H, s, CH2), 6.46 (1H, d,
J=7 Hz, ArH), 6.98–7.39 (m, 8H, ArH), 7.43 (2H, s, NH2)
ppm.
7′‑Amino‑2,2′,4′‑trioxo‑1′,2′,3′,4′‑tetrahydrospiro[indoline
‑3,5′‑pyrano[2,3‑d]pyrimidine]‑6′‑carbonitrile (6a) M.p.:
297–299 °C; FTIR (KBr): Vmax =3320, 3305, 2197, 1716,
1662, 1218 cm−1; 1H NMR (DMSO-d6, 400 MHz): δ=6.75
(1H, d, J=8.4 Hz, ArH), 6.83 (1H, t, J=7.2 Hz, ArH), 7.10
(1H, t, J=6.8 Hz, ArH), 7.43 (1H, d, J=11.2 Hz, ArH), 7.22
(2H, s, NH2), 10.15 (2H, s, 2 NH), 11.08 (1H, s, NH) ppm.
2‑Amino‑1′‑benzyl‑2′,5‑dioxo‑1′,2′,5,6,7,8‑hexahydrospiro[c
hromene‑4,3′‑indole]‑3‑carbonitrile (5f) M.p.: 282–284 °C;
FTIR (KBr): Vmax = 3371, 2958, 2193, 1718, 1678, 1219,
1011 cm−1; 1H NMR (DMSO-d6, 400 MHz): δ=1.71 (2H,
m, CH2), 1.95 (2H, t, J=7.2 Hz, CH2), 2.24 (2H, t, J=8 Hz
CH2), 4.89 (2H, s, CH2), 6.68 (1H, t, J=7.2 Hz, ArH), 6.95–
7.46 (8H, m, ArH), 7.52 (2H, s, NH2) ppm.
7′‑Amino‑5‑bromo‑1,1′,2,2′,3′,4′‑hexahydro‑2,2′,4′‑trioxo
spiro[indole‑3,5′‑pyrano[2,3‑d]pyrimidine]‑6′‑carbonitrile
(6b) M.p.: 221–223 °C; FTIR (KBr): Vmax = 3320, 3305,
2197, 1716, 1662, 1218; 1H NMR (DMSO-d6, 400 MHz):
σ= 66.75–7.43 (3H, m, ArH), 7.22 (2H, s, NH2), 10.15 (1H,
s, NH), 11.08 (1H, s, NH), 11.25 (1H, s, NH) ppm.
2‑Amino‑5‑oxo‑7,7‑dimethyl‑spiro[(4H)‑5,6,7,8‑tetrahydro‑
chromene‑4,3′‑(3′H)‑1′‑methylindol]‑(1′H)‑2′‑one‑3‑carbo
nitrile (5g) M.p.: 255–257 °C; FTIR (KBr): Vmax = 3372,
2958, 2192, 1706, 1667, 1221 cm−1; 1H NMR (DMSO-d6,
400 MHz): δ = 1.01 (3H, s, CH3), 1.05 (3H, s, CH3), 2.08
(2H, s, CH2), 2.51 (2H, s, CH2), 3.15 (3H, s, CH3), 6.98–
7.29 (4H, m, ArH), 7.30 (2H, s, NH2) ppm.
7′‑Amino‑5‑bromo‑1′,3′‑dimethyl‑2,2′,4′‑trioxo‑1′,
2′,3′,4′‑tetrahydrospiro[indoline‑3,5′‑pyrano[2,3‑d]
pyrimidine]‑6′‑carbonitrile (6c) M.p.: 295–297 °C; FTIR
(KBr): Vmax =3376, 2197, 1731, 1684, 1662, 1194 cm−1; 1
H
NMR (DMSO-d6, 400 MHz): δ=3.10 (6H, s, 2CH3), 6.76–
7.71(3H, m, ArH), 7.49 (2H, s, NH2), 10.73 (1H, s, NH)
ppm. 13C NMR (DMSO-d6, 100 MHz): δ=28.2, 29.7, 48.1,
56.9, 86.1, 113.5, 117.2, 118.0, 126.4, 130.6, 136.3, 140.6,
151.1, 152.6, 157.9, 156.9, 178.1 ppm.
2‑Amino‑1′‑methyl‑2′,5‑dioxo‑1′,2′,5,6,7,8‑hexahydrospir
o[chromene‑4,3′‑indoline]‑3‑carbonitrile (5h) M.p.: 245–
247 °C; FTIR (KBr): Vmax =3372, 2958, 2192, 1706, 1667,
1221 cm−1; 1H NMR (DMSO-d6, 400 MHz): δ = 1.9–1.93
(2H, m, CH2), 2.25 (2H, t, J = 6.8 Hz, CH2), 2.60 (2H, t,
J=6.8 Hz, CH2), 3.2 (3H, s, CH3), 6.91–7.23 (4H, m, ArH),
7.29 (2H, s, NH2) ppm; 13C NMR (DMSO-d6, 100 MHz):
δ=19.7, 26.5, 27.1, 36.5, 46.2, 58.1, 109.2, 112.1, 117.4,
122.6, 123.0, 128.5, 133.2, 143.6, 158.4, 166.1, 175.6,
195.2 ppm.
7′‑Amino‑1,1′,2,2′,3′,4′‑hexahydro‑1′,3′‑dimethyl‑2,2′,4′‑trio
xospiro[indole‑3,5′‑pyrano[2,3‑d]pyrimidine]‑6′‑carbonitrile
(6d) M.p.: 231–233 °C; FTIR (KBr): Vmax = 3428, 3317,
2924, 2000, 1693, 1652, 1130 cm−1; 1H NMR (DMSO-d6,
400 MHz): δ=3.01 (6H, s, 2CH3), 6.71–7.51 (4H, m, ArH),
7.69 (2H, s, NH2), 12.52 (1H, s, NH) ppm.
7′‑Amino‑2,4′‑dioxo‑2′‑thioxo‑1′,2′,3′,4′‑tetrahydrospiro
[indoline‑3,5′‑pyrano[2,3‑d]pyrimidine]‑6′‑carbonitrile
(6e) M.p.: 242–244 °C; FTIR (KBr): Vmax = 3427, 2202,
1694, 1187 cm−1; 1H NMR (DMSO-d6, 400 MHz): δ=6.77–
7.52 (m, 4H, ArH), 7.18 (s, 2H, NH2), 10.39 (s, 1H, NH),
11.35 (s, 1H, NH), 12.40 (s, 1H, NH) ppm; 13C NMR
(DMSO-d6, 100 MHz): δ=45.1, 57.5, 85.2, 112.4, 119.6,
123.7, 124.3, 129.1, 133.7, 142.6, 163.9, 166.1, 167.9,
176.6, 183.2 ppm.
Ethyl‑2‑amino‑7,7‑dimethyl‑2′,5‑dioxo‑5,6,7,8‑tetrahydr
ospiro[chromene‑4,3′‑indoline]‑3‑carboxylate (5i) M.p.:
258–260 °C; FTIR (KBr): Vmax =3371, 3245, 2956, 1718,
1670, 1219, 1011 cm−1. 1H NMR (DMSO-d6,400 MHz):
δ=0.90 (3H, t, J=4.8 Hz CH3), 1.15 (6H, s, 6CH3), 2.10
(2H, s, CH2), 2.35 (2H, s, CH2), 3.70 (2H, q, J = 6.3 Hz,
CH2), 6.64–7.12 (4H, m, ArH),7.80 (2H, s, NH2), 10.25 (1H,
s, NH) ppm.
Evaluation of in vitro antimicrobial activity
Ethyl‑2‑amino‑5′‑bromo‑7,7‑dimethyl‑2′,5‑dioxo‑5,6,7
,8‑tetrahydrospiro [chromene‑4,3′‑indoline]‑3‑carboxy
late (5j) M.p.: 257–259 °C; FTIR (KBr): Vmax = 3272,
2927, 1722, 1690, 1229, 1049 cm−1; 1H NMR (DMSO-d6,
400 MHz): δ = 0.92(t, J = 8.3 Hz, 3H, CH3), 1.04 (3H, s,
Some synthesized spirooxindole derivatives (5a, 5c, 5e, 5i,
5j) were screened for their antibacterial activity against 8
bacterial strains. The microorganisms used in this research
were provided by Iranian Research Organization for Science
1 3